The  logo

International

  1. Risks for women smokers taking proton pump inhibitors

    3 Feb 12 | 11.02 | International

    Women with a history of smoking may be at particular risk of hip fracture when using proton pump inhibitors (PPIs) long-term...

    more >

  2. Tighter controls needed over websites selling POMs to public

    3 Feb 12 | 11.40 | International

    Tighter controls are needed over the online advertising of prescription drugs, researchers have concluded...

    more >

  3. Dutasteride slows cancer progression, but should not be recommended

    3 Feb 12 | 10.53 | International

    Dutasteride, a 5α-reductase inhibitor, can delay disease progression for patients with low-risk prostate cancer, suggests research published

    more >

  4. Dutasteride slows early prostate cancer growth

    3 Feb 12 | 10.52 | International

    Dutasteride can slow progression of low-grade prostate cancer, suggest data published online in The Lancet (24 January 2012)...

    more >

  5. Poor outcomes when thalidomide added to advanced-NSCLC therapy

    3 Feb 12 | 10.48 | International

    Adding thalidomide to combined chemoradiotherapy does not improve survival rates for patients diagnosed with unresectable...

    more >

  6. Dabigatran increases risk of acute coronary syndromes, new meta-analysis suggests

    3 Feb 12 | 10.43 | International

    Dabigatran increases the risk of myocardial infarction and acute coronary syndrome (ACS) compared with standard anticoagulant therapy or placebo, suggest results of a meta-analysis

    more >

  7. Caffeine safe for preterm infants, but does not improve long-term outcomes

    3 Feb 12 | 10.09 | International

    Administration of caffeine to preterm neonates is safe, but is not associated with better long-term outcomes than placebo

    more >

  8. Childhood vaccinations rarely associated with anaphylaxis

    2 Feb 12 | 18.52 | International

    Vaccination rarely causes anaphylaxis in children, according to data published online

    more >

  9. Linezolid trumps vancomycin for MRSA pneumonia

    2 Feb 12 | 18.25 | International

    Linezolid achieves higher rates of clinical cure than vancomycin when used for the treatment of hospital-acquired pneumonia caused by meticillin-resistant Staphylococcus aureus

    more >

  10. Resources developed to help support patients with persistent pain

    2 Feb 12 | 18.08 | International

    New resources to help pharmacists manage patients with persistent pain have been developed by UCL School of Pharmacy and the United Kingdom Clinical Pharmacy Association

    more >